日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Distinct Molecular and Clinical Features of Specific Variants of KRAS Codon 12 in Pancreatic Adenocarcinoma.

胰腺腺癌中 KRAS 密码子 12 特定变异的独特分子和临床特征

Ardalan Bach, Ciner Aaron, Baca Yasmine, Hinton Andrew, Darabi Sourat, Kasi Anup, Lou Emil, Azqueta Jose Ignacio, Xiu Joanne, Datta Jashodeep, Shields Anthony F, Aguirre Andrew, Singh Harshabad, Shroff Rachna T, Pishvaian Michael J, Goel Sanjay

Potential benefit of treatment with MEK inhibitors and chemotherapy in BRAF-mutated KRAS wild-type pancreatic ductal adenocarcinoma patients: a case report

MEK抑制剂联合化疗治疗BRAF突变KRAS野生型胰腺导管腺癌患者的潜在益处:病例报告

Ardalan, Bach; Azqueta, Jose Ignacio; England, Jonathan; Eatz, Tiffany Alyssa